BioSpace News Archive

Business

Extendicare Announces 2023 Fourth Quarter and Year End Results

Extendicare Inc. reported results for the three and twelve months ended December 31, 2023.

March 7, 2024
·
18 min read
Drug Development

Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis

Kyverna Therapeutics, Inc. announced the signature of a collaboration agreement with Stanford University to allow the use of KYV-101, an investigational, anti-CD19 CAR T-cell therapy in an open label, phase 1 investigator-initiated trial in nine to twelve adult subjects with non-relapsing and progressive forms of multiple sclerosis.

March 7, 2024
·
6 min read
Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China

Silk Road Medical, a medical device company based in California USA and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products, ENROUTE® Transcarotid Neuroprotection System and ENROUTE® Transcarotid Stent System, in China.

March 7, 2024
·
5 min read
VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China

VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, announced that the Biologics License Application for Lonapegsomatropin was accepted by the China National Medical Products Administration.

March 7, 2024
·
2 min read